Skip to main content

Characterizing emerging molecular targets in ovarian cancer within standard therapeutic frameworks

Ovarian cancer remains one of the most lethal gynecological malignancies, with high mortality rates largely due to late-stage diagnosis and resistance to conventional therapies. Recent advances in molecular biology have identified several novel targets that offer potential for more effective and personalized treatment strategies. However, integrating these emerging molecular targets within existing therapeutic frameworks poses significant challenges and opportunities. This research aims to bridge this gap by thoroughly characterizing these new targets and evaluating their compatibility and effectiveness within current treatment paradigms.

Objectives:

  1. Identify and Analyze Emerging Molecular Targets:

    • Conduct a comprehensive review and experimental analysis to identify and validate novel molecular targets associated with ovarian cancer progression in various models.
  2. Evaluate Therapeutic Potential:

    • Assess the therapeutic potential of these emerging targets through preclinical studies.
  3. Integrate Within Standard Therapeutic Frameworks:

    • Develop strategies to explore these molecular targets into existing treatment protocols.

Le niveau de diplôme minimum du candidat

  • Academic bachelor

Les connaissances préexistantes nécessaires

  • Biology
  • Medical

La durée estimée

7 months

Le groupe d'experts

RadioPharma Research

SCK CEN Mentor

Primac Irina
Irina.Primac [at] sckcen.be
+32 (0)14 0

SCK CEN Co-mentor

Tabury Kevin
kevin.tabury [at] sckcen.be
+32 (0)14 33 28 16